TechNation Radio Podcast

On this week’s Tech Nation, Moira speaks with Dr Shana Kelley, President of Bioengineering and Head of Biohub Chicago,  about AI-Powered Biology - what is it? And what could it mean for the future of research? Then, Dr Harry Selker and Dr Atul Deshpande of Immediate Therapeutics tell us how they’ve come up with a speedy intervention for heart attacks. And, what exactly differentiates the NIH, the FDA, and the CDC? We take a closer look at that, and what they have in common.

On this week’s Tech Nation, Moira speaks with Pediatric surgeon Dr. Dana Suskind about her book, “Human Raised: Nurturing Connection, Curiosity & Lifelong Learning in the Age of AI”, and navigating the unique challenge AI presents for parents. Then, FUJIFILM Biotechnologies Chairman Toshi Iida joins to share how the company has gone way beyond film into the biotech landscape. And, do you ever feel like a virtual meeting isn’t going quite how you expected? Dr. Andrew Brodsky breaks down the science behind virtual communication.

On this week’s Tech Nation, Moira speaks with Dr. Richard Elwes about his book, “Huge Numbers: A Story of Counting Ambitiously, from 4 ½ to Fish 7”. They discuss what really makes a number “huge,” and how the way we count numbers is intertwined with the way we make sense of the world around us. Then, Founder, President, & CEO Lew Bender shares how Intensity Therapeutics is working to change how chemotherapy is administered to patients, with the hopes of reducing the toll it takes on the body.

On this week’s Tech Nation, Moira speaks with Journalist and author Barry Werth about how the United States’ pharmaceutical industry came to be. His book, “The Age of Cures: How American Scientists Saved Your Life”, tells the stories of several individuals who managed to revolutionize drug research and development, which gave way to major breakthroughs in medicine. Then, Jeff Liter of Luminary Therapeutics shares how his team is working to make advanced cell therapy easier to access and more affordable.

On this week’s Tech Nation, it’s always nice to have the answers, right?
Well… maybe that’s not true! Moira speaks with Columbia Professor Stuart Firestein about his new book, “It Could Be Otherwise: Science in the Age of Uncertainty,” and how we can embrace the not-always-knowing. Then, a potential biotech breakthrough for the treatment of gout - a disease that affects over 13 million people around the United States alone. Dr. James Mackay of Crystalys Therapeutics tells us about their new approach as they enter Phase III trials.

On this week’s Tech Nation, Moira speaks with Katie Prescott, author of “The Curious Case of Mike Lynch”, about a titan of the Tech world, who lost his life along with his daughter and others when his luxury yacht tragically sank off the coast of Sicily. What happened leading up to that day, and is there more to the story? Then, you may have heard of peptides, but what exactly are they? Dr. Karsten Eastman of Sethera Therapeutics explains how they work, and how Sethera plans to develop enhanced peptides to create new medicines, starting with triple-negative breast cancer.

On this week’s Tech Nation, Moira speaks with Dr. Martin Borch Jensen and Dr. Francisco LePort from Gordian Biotechnology, who are working on diseases of ageing before they even appear. Then, Tech Nation Health Chief Correspondent, Dr. Daniel Kraft, explains why mobility is the new vital sign. And Erica Dhawan, Author of Digital Body Language, tells us how to navigate the misinterpretations of digital communication.

On this week’s Tech Nation, Moira speaks with Stanford University Research Scholar Adrienne Mayor, to discuss what ancient myths tell us about the deep history of planet earth in her book "Mythopedia". Then in biotech, Dr. Ned Swanson, President and Chief Medical Officer of Polarity Bio, tells us about their approach to healing serious, hard-to-treat skin wounds. In early trials, it’s twice as effective as the current treatment for diabetic foot ulcers.

On this week’s Tech Nation, Moira speaks with University of Chicago professor, Dr. Marc Berman, who tells us about "Nature and the Mind: The Science of How Nature Improves Cognitive, Physical, and Social Well-Being." Then in biotech, Dr. Joshua Hare, Co-Founder and Chief Scientific Officer of Longeveron, gives us the inside look on how they are testing the use of stem cells to treat babies born with a serious congenital heart defect.

On this week’s Tech Nation, Moira speaks with Henry Abbott, former ESPN journalist and author of "Ballistic: The New Science of Injury-Free Athletic Performance". Then, Dr Lorin Johnson, CSO of Glycyx Therapeutics, explains why opioids prescribed for cancer pain may be limiting the effectiveness of immunotherapy, and how their upcoming clinical trials hope to fix it.